Trial intelligence / Profile preview

Topotect for Anthracycline Extravasation

NCT00548704Phase 3Completed

Sponsor
Valerio Therapeutics
Start
Apr 2002
Primary completion
Aug 2005
Modality
Small Molecules
Countries
5
01

Overview

A Phase 3 trial of dexrazoxane in Anthracycline extravasation, sponsored by Valerio Therapeutics. Started Apr 2002; status: completed.

02

Drugs

dexrazoxane
03

Conditions

Anthracycline extravasation

Beyond the preview

Go deeper on NCT00548704.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00548704.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call